Cargando…

SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia

RATIONALE: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19 pneumonia. We hypothesize that SARS-CoV-2 causes alveolar injury and hypoxemia by damaging mitochondria in airway epithelial cells (AEC) and pulmonary artery smooth muscle cells (PASMC), triggering apoptosis and...

Descripción completa

Detalles Bibliográficos
Autores principales: Archer, Stephen L., Dasgupta, Asish, Chen, Kuang-Hueih, Wu, Danchen, Baid, Kaushal, Mamatis, John E., Gonzalez, Victoria, Read, Austin, Bentley, Rachel ET., Martin, Ashley Y., Mewburn, Jeffrey D., Dunham-Snary, Kimberly J., Evans, Gerald A., Levy, Gary, Jones, Oliver, Al-Qazazi, Ruaa, Ring, Brooke, Alizadeh, Elahe, Hindmarch, Charles CT., Rossi, Jenna, Lima, Patricia DA., Falzarano, Darryl, Banerjee, Arinjay, Colpitts, Che C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558649/
https://www.ncbi.nlm.nih.gov/pubmed/36334378
http://dx.doi.org/10.1016/j.redox.2022.102508
_version_ 1784807486777196544
author Archer, Stephen L.
Dasgupta, Asish
Chen, Kuang-Hueih
Wu, Danchen
Baid, Kaushal
Mamatis, John E.
Gonzalez, Victoria
Read, Austin
Bentley, Rachel ET.
Martin, Ashley Y.
Mewburn, Jeffrey D.
Dunham-Snary, Kimberly J.
Evans, Gerald A.
Levy, Gary
Jones, Oliver
Al-Qazazi, Ruaa
Ring, Brooke
Alizadeh, Elahe
Hindmarch, Charles CT.
Rossi, Jenna
Lima, Patricia DA.
Falzarano, Darryl
Banerjee, Arinjay
Colpitts, Che C.
author_facet Archer, Stephen L.
Dasgupta, Asish
Chen, Kuang-Hueih
Wu, Danchen
Baid, Kaushal
Mamatis, John E.
Gonzalez, Victoria
Read, Austin
Bentley, Rachel ET.
Martin, Ashley Y.
Mewburn, Jeffrey D.
Dunham-Snary, Kimberly J.
Evans, Gerald A.
Levy, Gary
Jones, Oliver
Al-Qazazi, Ruaa
Ring, Brooke
Alizadeh, Elahe
Hindmarch, Charles CT.
Rossi, Jenna
Lima, Patricia DA.
Falzarano, Darryl
Banerjee, Arinjay
Colpitts, Che C.
author_sort Archer, Stephen L.
collection PubMed
description RATIONALE: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19 pneumonia. We hypothesize that SARS-CoV-2 causes alveolar injury and hypoxemia by damaging mitochondria in airway epithelial cells (AEC) and pulmonary artery smooth muscle cells (PASMC), triggering apoptosis and bioenergetic impairment, and impairing hypoxic pulmonary vasoconstriction (HPV), respectively. OBJECTIVES: We examined the effects of: A) human betacoronaviruses, SARS-CoV-2 and HCoV-OC43, and individual SARS-CoV-2 proteins on apoptosis, mitochondrial fission, and bioenergetics in AEC; and B) SARS-CoV-2 proteins and mouse hepatitis virus (MHV-1) infection on HPV. METHODS: We used transcriptomic data to identify temporal changes in mitochondrial-relevant gene ontology (GO) pathways post-SARS-CoV-2 infection. We also transduced AECs with SARS-CoV-2 proteins (M, Nsp7 or Nsp9) and determined effects on mitochondrial permeability transition pore (mPTP) activity, relative membrane potential, apoptosis, mitochondrial fission, and oxygen consumption rates (OCR). In human PASMC, we assessed the effects of SARS-CoV-2 proteins on hypoxic increases in cytosolic calcium, an HPV proxy. In MHV-1 pneumonia, we assessed HPV via cardiac catheterization and apoptosis using the TUNEL assay. RESULTS: SARS-CoV-2 regulated mitochondrial apoptosis, mitochondrial membrane permeabilization and electron transport chain (ETC) GO pathways within 2 hours of infection. SARS-CoV-2 downregulated ETC Complex I and ATP synthase genes, and upregulated apoptosis-inducing genes. SARS-CoV-2 and HCoV-OC43 upregulated and activated dynamin-related protein 1 (Drp1) and increased mitochondrial fission. SARS-CoV-2 and transduced SARS-CoV-2 proteins increased apoptosis inducing factor (AIF) expression and activated caspase 7, resulting in apoptosis. Coronaviruses also reduced OCR, decreased ETC Complex I activity and lowered ATP levels in AEC. M protein transduction also increased mPTP opening. In human PASMC, M and Nsp9 proteins inhibited HPV. In MHV-1 pneumonia, infected AEC displayed apoptosis and HPV was suppressed. BAY K8644, a calcium channel agonist, increased HPV and improved SpO(2). CONCLUSIONS: Coronaviruses, including SARS-CoV-2, cause AEC apoptosis, mitochondrial fission, and bioenergetic impairment. SARS-CoV-2 also suppresses HPV by targeting mitochondria. This mitochondriopathy is replicated by transduction with SARS-CoV-2 proteins, indicating a mechanistic role for viral-host mitochondrial protein interactions. Mitochondriopathy is a conserved feature of coronaviral pneumonia that may exacerbate hypoxemia and constitutes a therapeutic target.
format Online
Article
Text
id pubmed-9558649
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-95586492022-10-16 SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia Archer, Stephen L. Dasgupta, Asish Chen, Kuang-Hueih Wu, Danchen Baid, Kaushal Mamatis, John E. Gonzalez, Victoria Read, Austin Bentley, Rachel ET. Martin, Ashley Y. Mewburn, Jeffrey D. Dunham-Snary, Kimberly J. Evans, Gerald A. Levy, Gary Jones, Oliver Al-Qazazi, Ruaa Ring, Brooke Alizadeh, Elahe Hindmarch, Charles CT. Rossi, Jenna Lima, Patricia DA. Falzarano, Darryl Banerjee, Arinjay Colpitts, Che C. Redox Biol Research Paper RATIONALE: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19 pneumonia. We hypothesize that SARS-CoV-2 causes alveolar injury and hypoxemia by damaging mitochondria in airway epithelial cells (AEC) and pulmonary artery smooth muscle cells (PASMC), triggering apoptosis and bioenergetic impairment, and impairing hypoxic pulmonary vasoconstriction (HPV), respectively. OBJECTIVES: We examined the effects of: A) human betacoronaviruses, SARS-CoV-2 and HCoV-OC43, and individual SARS-CoV-2 proteins on apoptosis, mitochondrial fission, and bioenergetics in AEC; and B) SARS-CoV-2 proteins and mouse hepatitis virus (MHV-1) infection on HPV. METHODS: We used transcriptomic data to identify temporal changes in mitochondrial-relevant gene ontology (GO) pathways post-SARS-CoV-2 infection. We also transduced AECs with SARS-CoV-2 proteins (M, Nsp7 or Nsp9) and determined effects on mitochondrial permeability transition pore (mPTP) activity, relative membrane potential, apoptosis, mitochondrial fission, and oxygen consumption rates (OCR). In human PASMC, we assessed the effects of SARS-CoV-2 proteins on hypoxic increases in cytosolic calcium, an HPV proxy. In MHV-1 pneumonia, we assessed HPV via cardiac catheterization and apoptosis using the TUNEL assay. RESULTS: SARS-CoV-2 regulated mitochondrial apoptosis, mitochondrial membrane permeabilization and electron transport chain (ETC) GO pathways within 2 hours of infection. SARS-CoV-2 downregulated ETC Complex I and ATP synthase genes, and upregulated apoptosis-inducing genes. SARS-CoV-2 and HCoV-OC43 upregulated and activated dynamin-related protein 1 (Drp1) and increased mitochondrial fission. SARS-CoV-2 and transduced SARS-CoV-2 proteins increased apoptosis inducing factor (AIF) expression and activated caspase 7, resulting in apoptosis. Coronaviruses also reduced OCR, decreased ETC Complex I activity and lowered ATP levels in AEC. M protein transduction also increased mPTP opening. In human PASMC, M and Nsp9 proteins inhibited HPV. In MHV-1 pneumonia, infected AEC displayed apoptosis and HPV was suppressed. BAY K8644, a calcium channel agonist, increased HPV and improved SpO(2). CONCLUSIONS: Coronaviruses, including SARS-CoV-2, cause AEC apoptosis, mitochondrial fission, and bioenergetic impairment. SARS-CoV-2 also suppresses HPV by targeting mitochondria. This mitochondriopathy is replicated by transduction with SARS-CoV-2 proteins, indicating a mechanistic role for viral-host mitochondrial protein interactions. Mitochondriopathy is a conserved feature of coronaviral pneumonia that may exacerbate hypoxemia and constitutes a therapeutic target. Elsevier 2022-10-13 /pmc/articles/PMC9558649/ /pubmed/36334378 http://dx.doi.org/10.1016/j.redox.2022.102508 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Paper
Archer, Stephen L.
Dasgupta, Asish
Chen, Kuang-Hueih
Wu, Danchen
Baid, Kaushal
Mamatis, John E.
Gonzalez, Victoria
Read, Austin
Bentley, Rachel ET.
Martin, Ashley Y.
Mewburn, Jeffrey D.
Dunham-Snary, Kimberly J.
Evans, Gerald A.
Levy, Gary
Jones, Oliver
Al-Qazazi, Ruaa
Ring, Brooke
Alizadeh, Elahe
Hindmarch, Charles CT.
Rossi, Jenna
Lima, Patricia DA.
Falzarano, Darryl
Banerjee, Arinjay
Colpitts, Che C.
SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia
title SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia
title_full SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia
title_fullStr SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia
title_full_unstemmed SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia
title_short SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia
title_sort sars-cov-2 mitochondriopathy in covid-19 pneumonia exacerbates hypoxemia
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558649/
https://www.ncbi.nlm.nih.gov/pubmed/36334378
http://dx.doi.org/10.1016/j.redox.2022.102508
work_keys_str_mv AT archerstephenl sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia
AT dasguptaasish sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia
AT chenkuanghueih sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia
AT wudanchen sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia
AT baidkaushal sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia
AT mamatisjohne sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia
AT gonzalezvictoria sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia
AT readaustin sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia
AT bentleyrachelet sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia
AT martinashleyy sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia
AT mewburnjeffreyd sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia
AT dunhamsnarykimberlyj sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia
AT evansgeralda sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia
AT levygary sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia
AT jonesoliver sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia
AT alqazaziruaa sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia
AT ringbrooke sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia
AT alizadehelahe sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia
AT hindmarchcharlesct sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia
AT rossijenna sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia
AT limapatriciada sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia
AT falzaranodarryl sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia
AT banerjeearinjay sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia
AT colpittschec sarscov2mitochondriopathyincovid19pneumoniaexacerbateshypoxemia